ArticleBlood2015

Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy.

Garyfalia Karponi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.